Skip to main content
ANTX logo

ANTX · AN2 Therapeutics, Inc. · Proposed Sales

Track ANTX — free
$3.60 +0.04 (+1.12%) At close · Oct 21
Market Cap
$142.08M
Shares
37.74M
Volume · Oct 21 177.37K Avg daily vol (3M) 249.97K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-08-17 Readnour Robin Shane 1,012,000
2024-08-15 RA Capital Healthcare Fund LP 1,699,998
2024-08-15 RA Capital Nexus Fund II, L.P. 299,999
2024-01-18 Z3 TRUST 100,000
2024-01-16 Adjuvant Global Health Technology Fund DE, L.P. 15,907
2024-01-16 Adjuvant Global Health Technology Fund, L.P. 84,093
2024-01-10 MGC VENTURE PARTNERS QP 2018 ,LP 11,033
2024-01-10 MGC VENTURE PARTNERS 2018 ,LP 9,443
2024-01-02 ERIC EASOM 2,777
2024-01-02 KEVIN KRAUSE 10,000
2023-11-14 ADJUVANT CAPITAL GP, L.P. 1,810
2023-10-02 ADJUVANT CAPITAL GP, L.P. 5,672
2023-09-29 ADJUVANT CAPITAL GP, L.P. 86,398
2023-08-23 ADJUVANT CAPITAL GP, L.P. 30,000
Showing 1–14 of 14 filings
Key facts CIK 1880438 CUSIP 037326105 13F (30d) 8 filings 4 filers Visit website Investor relations